To include your compound in the COVID-19 Resource Center, submit it here.

AlCana, Alnylam, University of British Columbia deal

Alnylam extended by one year to 2012 a 2009 deal to discover cationic lipid nanoparticles for the systemic delivery of RNAi

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE